Axsome’s Phase III GEMINI trial of depression drug meets endpoints

Major depressive disorder is a debilitating, chronic disorder characterised by low mood, among other symptoms. Credit: Małgorzata Tomczak from Pixabay.



  • Axsome GEMINI trial